Get every episode summarized
Each time WSJ Minute Briefing publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Plus: Shares in Novo Nordisk rally after the FDA clamps down on companies making compound versions of weight-loss drug Wegovy. And SpaceX delays a planned Mars mission to focus on Nasa’s next moon landing. Daniel Bach hosts.
Sign up for WSJ’s free What’s News newsletter.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time WSJ Minute Briefing publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from WSJ Minute Briefing
Dow Climbs Amid Hopes for Hormuz Deal
WSJ Minute Briefing
In Loss for Anthropic, U.S. Appeals Court Upholds Pentagon’s Security-Risk Label
WSJ Minute Briefing
Falling Oil Prices Offer Relief to Global Markets
WSJ Minute Briefing
Record High Bond Yields Drag Stocks Down
WSJ Minute Briefing